João L. Carapinha

Earlier Surgery Recommended for Heart-Valve Patients: New Study Insights
Overview of NICE’s Elranatamab Managed Access Agreement
HIQA’s Strategic Blueprint for Health Care Excellence: Draft Corporate ...
Rifaximin Use Linked to Daptomycin Resistance: Implications for Antibiotic St...
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
Innovative Pricing and Payment Models for Health Technologies